These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 7281700)
1. [Drug therapy of hyperlipidemias]. Wolfram G Wien Med Wochenschr; 1981; 131(13-14):333-8. PubMed ID: 7281700 [No Abstract] [Full Text] [Related]
2. Clofibrate and related compounds in hyperlipoproteinaemia. A review. Gustafson A Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983 [No Abstract] [Full Text] [Related]
3. Treatment of hyperlipidemia. Levy RI; Morganroth J; Rifkind BM N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888 [No Abstract] [Full Text] [Related]
4. Does hypolipidemic therapy prevent coronary heart disease? Rifkind BM; Levy RI Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303 [No Abstract] [Full Text] [Related]
5. Should hyperlipidemia be treated? Available agents and clinical results. Gotto AM Cardiovasc Res Cent Bull; 1978; 17(1):3-27. PubMed ID: 223761 [No Abstract] [Full Text] [Related]
6. [Selective therapy of hyperlipidemias]. Greten H MMW Munch Med Wochenschr; 1978 Dec; 120(50):1661-2. PubMed ID: 214703 [No Abstract] [Full Text] [Related]
11. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia]. Bucalossi A; Buzzelli G; D'Alessandro A Clin Ter; 1979 Apr; 89(2):127-49. PubMed ID: 226307 [No Abstract] [Full Text] [Related]
12. [Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV]. Jantke J; Schwartzkopff W; Zschiedrich M Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():392-5. PubMed ID: 206057 [No Abstract] [Full Text] [Related]
13. Effect of hypolipidemic drugs on serum lipoproteins. Carlson LA; Olsson AG Prog Biochem Pharmacol; 1979; 15():238-57. PubMed ID: 224397 [No Abstract] [Full Text] [Related]
14. [Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex]. Loizzi P; Terlizzi N Reumatismo; 1975; 27(1):157-62. PubMed ID: 184507 [No Abstract] [Full Text] [Related]
15. Gemfibrozil treatment: a comparison with clofibrate. Howard AN; Ghosh P Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609 [TBL] [Abstract][Full Text] [Related]
16. [Plasma glycosaminoglycans in patients with coronary disease and hyperlipidemia]. Giannini SD; Strunz CM; Forti N; Credidio Rde A; Diament J; Dereviacki BE; de Góis JM; de Serro-Azul LG Arq Bras Cardiol; 1986 May; 46(5):307-10. PubMed ID: 3471185 [No Abstract] [Full Text] [Related]
17. [Diet therapy in hyperlipoproteinemias]. Canzler H Z Allgemeinmed; 1974 Jan; 50(2):53-61. PubMed ID: 4361378 [No Abstract] [Full Text] [Related]
18. Management of dyslipidemia. Akel MM; Salti I J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421 [No Abstract] [Full Text] [Related]
19. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices]. Herrmann W; Reuter W Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524 [No Abstract] [Full Text] [Related]
20. [Study of serum lipoproteins in diabetes mellitus. Clinicometabolic significance]. Strat C; Andriescu E; Lungu I; Ilarion FL; Terek C Rev Med Chir Soc Med Nat Iasi; 1974; 78(3):565-72. PubMed ID: 4375841 [No Abstract] [Full Text] [Related] [Next] [New Search]